Cancer Antigen 72-4 (CA72-4) Detection Kit (Chemiluminescence Immunoassay Method) - NMPA Registration 浙械注准20242401051
Access comprehensive regulatory information for Cancer Antigen 72-4 (CA72-4) Detection Kit (Chemiluminescence Immunoassay Method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 浙械注准20242401051 and owned by Acon Biotech (Hangzhou) Co., Ltd.. The device was approved on January 16, 2024.
This page provides complete registration details including registrant information, province location (Zhejiang), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
This kit is used for the quantitative detection of cancer antigen 72-4 (CA72-4) in human serum or plasma in vitro. This reagent is mainly used for dynamic monitoring of patients with malignant tumors to assist in judging the disease process or treatment effect, and cannot be used as the basis for early diagnosis or diagnosis of malignant tumors, and cannot be used for tumor screening in the general population.
本试剂盒用于体外定量检测人血清或血浆中癌抗原72-4（CA72-4）的含量。本试剂主要用于对恶性肿瘤患者进行动态监测以辅助判断疾病进程或治疗效果，不能作为恶性肿瘤早期诊断或确诊的依据，不能用于普通人群的肿瘤筛查。
Reagent 1 (R1), Reagent 2 (R2), Reagent M, Calibrator (2 levels), Control L, Control M. (Please refer to the manual for details)
试剂1（R1），试剂2（R2），试剂M，校准品（2个水平），质控品L，质控品M。（具体详见说明书）
This product is stored at 2~8°C and is valid for 12 months.
本产品于2～8℃下保存，有效期12个月。